Definitive Contract 75N95018C00027
Award Date
8/14/18
Potential Completion Date
3/14/22
Potential Value
$1.7M
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92126, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for peptide synthesis facility services. Specifically, Polypeptide Labs will provide storage and stability studies of drug substances and products in support of the agency's biomedical research efforts. Performance will take place in San Diego, California over a 10-month...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for a peptide synthesis facility to conduct storage and stability studies of drug substances and products. As the prime contractor, Polypeptide Labs will perform the requested studies at its location in San Diego, California over a one year period from August 1, 2016...
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation. Polypeptide Labs is a specialized manufacturer of peptides and related compounds,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for a peptide synthesis facility to conduct storage and stability studies of drug substances and products. Polypeptide Laboratories San Diego, LLC will perform the requested studies at its location in San Diego, California over a six-month period from February 1, 2016...
Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the National Institutes of Health's National Institute on Drug Abuse. The $598,190 delivery order is for the synthesis and distribution of opioid and related peptides over the one year period of performance from February 15, 2024 through February 14, 2025. The underlying indefinite delivery contract, awarded in 2022...
This federal contract award, valued at $200,532.62, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, a for-profit biotechnology and pharmaceutical research company. The contract is for the synthesis and distribution of opioid and related peptides, which supports critical biomedical research initiatives. This award is associated with a larger $2,781,317 Indefinite Delivery...
This is a $595,094.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC for the synthesis and distribution of opioid and related peptides. The period of performance is from February 15, 2025, to February 14, 2026. This task order is part of a larger $2,781,317 Indefinite Delivery Contract (IDC) that Polypeptide Laboratories holds with NIDA...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...
This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,326.00 firm fixed price purchase order to JPT Peptide Technologies GMBH, a foreign-owned, for-profit manufacturer of goods, for custom peptide synthesis. The award, which did not have any set-aside designation, supports research related to cancer, COVID-19, allergies, and infectious diseases. JPT Peptide Technologies has received...